<- Go Home
Tottenham Acquisition I Limited
As of December 30, 2020, was acquired by Clene Nanomedicine Inc., in a reverse merger transaction.
Market Cap
$14.7M
Volume
29.5K
Cash and Equivalents
$440.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$17.50
52 Week Low
$6.40
Dividend
N/A
Price / Book Value
2.94
Price / Earnings
-16.02
Price / Tangible Book Value
2.94
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$1.1M
Return on Equity
9.18%
Return on Assets
-1.81
Cash and Short Term Investments
$440.1K
Debt
$3.2M
Equity
$5.0M
Revenue
N/A
Unlevered FCF
-$528.6K
Sector
Capital Markets
Category
N/A